Allspring Global Investments
KYNB

Allspring Global Investments’s Kyntra Bio KYNB Stock Holding History

Allspring Global Investments’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-824
Closed -$17.8K – 2405
2023
Q3 		$17.8K Buy
824
+369
+81% +$14.5K ﹤0.01% 2531
2023
Q2 		$30.7K Sell
455
-1,934
-81% -$800K ﹤0.01% 2395
2023
Q1 		$1.11M Buy
2,389
+1,978
+481% +$1.05M ﹤0.01% 1397
2022
Q4 		$165K Buy
411
+57
+16% +$21.8K ﹤0.01% 1889
2022
Q3 		$115K Buy
354
+142
+67% +$45.7K ﹤0.01% 2020
2022
Q2 		$55K Sell
212
-1,342
-86% -$343K ﹤0.01% 2234
2022
Q1 		$467K Buy
1,554
+50
+3% +$17.4K ﹤0.01% 2254
2021
Q4 		$530K Buy
+1,504
New +$468K ﹤0.01% 2262

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's KYNB Position: Q4 2023 in Review

Allspring Global Investments sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 824 shares — an estimated $17.8K sold.

Allspring Global Investments first reported a position in KYNB in Q4 2021 and held it in 8 quarters. The position peaked at $1.11M in Q1 2023. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

  • Allspring Global Investments reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 824 Kyntra Bio shares in Q4 2023, an estimated $17.8K.
  • Allspring Global Investments first reported a position in Kyntra Bio in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Kyntra Bio position peaked at $1.11M in Q1 2023.
  • 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.